This stock has sank, sank, and sank further, consistently underperforming the market. A few of the brokers have downgraded the stock based on a perceived maturity of the sleep apnea market in the US. The the aud/US exchange rate isn't helping since manufacturing costs are based mostly here in Australia. Still, with a or around 17 which isn't too bad for the health care industry. Not sure whether to keep holding or let go of this stock. What are others opinion?
This stock has sank, sank, and sank further, consistently...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$38.15 |
Change
0.070(0.18%) |
Mkt cap ! $22.38B | |||
| Open | High | Low | Value | Volume |
| $38.10 | $38.22 | $37.91 | $30.20M | 792.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 956 | $38.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $38.15 | 2018 | 1 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| RMD (ASX) Chart |
